IL6 and psoriasis: This study demonstrates that CuE alleviates psoriasis-like symptoms by inhibiting the IL-6-STAT3-MDK signaling axis, positioning it as a potential novel therapeutic targeting fibroblast-mediated immune interactions in psoriasis.